Showing 35,232 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

PrEP

When will Europe get PrEP?

News
23 October 2015
Hepatitis C treatment

Viekira Pak, Technivie May Up Serious Liver Injury Risk: FDA

Editor's pick
Medscape
23 October 2015
Treatment simplification strategies

Can dolutegravir dual therapy or monotherapy produce and maintain HIV suppression?

News
23 October 2015
Migrants, refugees & displaced people

The majority of migrants living with HIV in Europe may have acquired HIV in their new country

News
23 October 2015
HIV treatment

Benefits of early HIV treatment are clear, but issues raised by START and D:A:D remain unresolved

News
23 October 2015
Harm reduction

Needle and syringe exchanges need to adapt to meet the needs of people who inject steroids and image-enhancing drugs

News
22 October 2015
Drug-resistant TB

Newest MDR-TB drug prices could fall by up to 95% through generic production

News
22 October 2015
TB diagnosis

TB death rate four times higher in Eastern Europe due to lack of HIV treatment after TB diagnosis

News
22 October 2015
TB transmission & prevention

Three-month isoniazid/pyrazinamide regimen prevents TB as well as 6-month isoniazid in people living with HIV

News
22 October 2015
New & experimental hepatitis C treatment

'Dallas Buyers' Club' for Hep C treatments under investigation

Editor's pick
Sydney Morning Herald
22 October 2015
PrEP

Here's why Australians are missing out on the HIV prevention pill

Editor's pick
The Conversation AU
22 October 2015
Drug policy & policing

UN drugs office urged to publish leaked paper backing decriminalisation

Editor's pick
Daily Mail
22 October 2015
Drug policy & policing

The truth behind the UNODC's leaked decriminalisation paper

Editor's pick
Transform
22 October 2015
HIV prevention policy

Can Europe reach the 90-90-90 target for HIV treatment by 2020?

News
22 October 2015
PrEP science

Modest bone loss seen in young men taking Truvada for pre-exposure prophylaxis

News
22 October 2015
Harm reduction

Why is injecting equipment re-used? Drug users do their own research to find out

News
21 October 2015
Retention & linkage to care

Peer workers improve drug users’ engagement with HIV care in Ukraine

News
21 October 2015
PrEP

HIV prevention activists launch drive to educate and agitate for HIV PrEP access

Editor's pick
Prepster
21 October 2015
HIV treatment

One third of people with HIV in US study are not virally suppressed on antiretroviral therapy

News
21 October 2015
The search for a cure

HIV Cure Research: NIH Scientists Create Two-Headed Protein to Deplete HIV Reservoir

Editor's pick
National Institute of Allergy and Infectious Diseases (NIAID)
21 October 2015
PrEP policies & guidelines

How do we treat the world? Experts discuss moving to universal HIV treatment

News
21 October 2015
Hepatitis & HIV

Sofosbuvir + daclatasvir demonstrates high cure rates for people with HIV and HCV co-infection

News
21 October 2015
Drug policy & policing

United Nations denies 'global drug decriminalisation' claim by Sir Richard Branson

Editor's pick
The Telegraph
20 October 2015
Ageing & HIV

One in six HIV-infected people in UK is aged over 55

Editor's pick
Onmedica
20 October 2015